Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionDNA photolyase activity

CRY2 CRY1

4.97e-062452GO:0003913
GeneOntologyMolecularFunctionDNA (6-4) photolyase activity

CRY2 CRY1

4.97e-062452GO:0003914
GeneOntologyMolecularFunctiondeoxyribodipyrimidine photo-lyase activity

CRY2 CRY1

4.97e-062452GO:0003904
GeneOntologyMolecularFunctionblue light photoreceptor activity

CRY2 CRY1

4.97e-062452GO:0009882
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

CRY2 CHD8 CHD7 POLE RAD54L CRY1

2.56e-05262456GO:0140097
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

CHD8 CHD7 RAD54L

7.88e-0537453GO:0140658
GeneOntologyMolecularFunctioncalmodulin binding

ASPM MYO1G MYO5A ADCY8 SCN5A

1.63e-04230455GO:0005516
GeneOntologyMolecularFunctionATP-dependent activity

MYO1G CHD8 CHD7 MYO5A SMC3 ATAD3A RAD54L

4.13e-04614457GO:0140657
GeneOntologyMolecularFunctioncatalytic activity, acting on a nucleic acid

CRY2 CHD8 CHD7 POLE RAD54L POLR2F CRY1

5.54e-04645457GO:0140640
GeneOntologyMolecularFunctionphotoreceptor activity

CRY2 CRY1

6.61e-0417452GO:0009881
GeneOntologyMolecularFunctionphosphatidylinositol kinase activity

PIK3C2A PI4KA

1.56e-0326452GO:0052742
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYO1G MYO5A SMC3

2.38e-03118453GO:0003774
GeneOntologyMolecularFunctionATP-dependent activity, acting on DNA

CHD8 CHD7 RAD54L

2.93e-03127453GO:0008094
GeneOntologyMolecularFunctionATP hydrolysis activity

CHD8 CHD7 SMC3 ATAD3A RAD54L

3.03e-03441455GO:0016887
GeneOntologyMolecularFunctionmicrofilament motor activity

MYO1G MYO5A

3.32e-0338452GO:0000146
GeneOntologyMolecularFunctionlipid kinase activity

PIK3C2A PI4KA

3.85e-0341452GO:0001727
GeneOntologyMolecularFunctionFAD binding

CRY2 CRY1

4.42e-0344452GO:0071949
GeneOntologyBiologicalProcessblue light signaling pathway

CRY2 CRY1

4.87e-062462GO:0009785
GeneOntologyBiologicalProcesscellular response to blue light

CRY2 CRY1

4.87e-062462GO:0071483
GeneOntologyBiologicalProcessnegative regulation of circadian rhythm

CRY2 DRD2 CRY1

5.70e-0616463GO:0042754
GeneOntologyBiologicalProcessmaintenance of location

CRY2 ASPM CHD7 DRD2 ACACB MYO5A CRY1

2.56e-05396467GO:0051235
GeneOntologyBiologicalProcessnegative regulation of corticosteroid hormone secretion

CRY2 CRY1

4.85e-055462GO:2000847
GeneOntologyBiologicalProcessnegative regulation of steroid hormone secretion

CRY2 CRY1

4.85e-055462GO:2000832
GeneOntologyBiologicalProcessnegative regulation of glucocorticoid secretion

CRY2 CRY1

4.85e-055462GO:2000850
GeneOntologyBiologicalProcesssecretion

CRY2 MYO1G CHD7 DRD2 WDR41 ACACB MYO5A PIK3C2A ADCY8 SEC24A CRY1

5.85e-0512214611GO:0046903
GeneOntologyBiologicalProcessresponse to blue light

CRY2 CRY1

7.26e-056462GO:0009637
GeneOntologyBiologicalProcessnegative regulation of glucocorticoid receptor signaling pathway

CRY2 CRY1

7.26e-056462GO:2000323
GeneOntologyBiologicalProcesssecretion by cell

CRY2 MYO1G CHD7 DRD2 WDR41 MYO5A PIK3C2A ADCY8 SEC24A CRY1

9.53e-0510644610GO:0032940
GeneOntologyBiologicalProcessnegative regulation of dopamine secretion

DRD2 MYO5A

1.01e-047462GO:0033602
GeneOntologyBiologicalProcessnegative regulation of secretion by cell

CRY2 DRD2 WDR41 MYO5A CRY1

1.11e-04214465GO:1903531
GeneOntologyBiologicalProcessregulation of lipid localization

CRY2 IRAK1 ACACB SEC24A CRY1

1.14e-04215465GO:1905952
GeneOntologyBiologicalProcessexport from cell

CRY2 MYO1G CHD7 DRD2 WDR41 MYO5A PIK3C2A ADCY8 SEC24A CRY1

1.85e-0411534610GO:0140352
GeneOntologyBiologicalProcessnegative regulation of secretion

CRY2 DRD2 WDR41 MYO5A CRY1

1.86e-04239465GO:0051048
GeneOntologyBiologicalProcessregulation of secretion by cell

CRY2 CHD7 DRD2 WDR41 MYO5A ADCY8 SEC24A CRY1

2.06e-04740468GO:1903530
GeneOntologyBiologicalProcesslipid localization

CRY2 IRAK1 DRD2 XKR6 ACACB SEC24A CRY1

2.36e-04565467GO:0010876
GeneOntologyBiologicalProcessnegative regulation of lipid transport

CRY2 IRAK1 CRY1

2.65e-0456463GO:0032369
GeneOntologyBiologicalProcessnegative regulation of transport

CRY2 IRAK1 DRD2 WDR41 MYO5A PIK3C2A CRY1

2.98e-04587467GO:0051051
GeneOntologyBiologicalProcessregulation of glucocorticoid receptor signaling pathway

CRY2 CRY1

3.17e-0412462GO:2000322
GeneOntologyBiologicalProcesshormone secretion

CRY2 CHD7 DRD2 MYO5A ADCY8 CRY1

3.23e-04420466GO:0046879
GeneOntologyBiologicalProcessregulation of secretion

CRY2 CHD7 DRD2 WDR41 MYO5A ADCY8 SEC24A CRY1

3.52e-04801468GO:0051046
GeneOntologyBiologicalProcessresponse to inactivity

DRD2 SCN5A

3.74e-0413462GO:0014854
GeneOntologyBiologicalProcessnegative regulation of synaptic transmission, glutamatergic

DRD2 MYO5A

3.74e-0413462GO:0051967
GeneOntologyBiologicalProcesshormone transport

CRY2 CHD7 DRD2 MYO5A ADCY8 CRY1

3.76e-04432466GO:0009914
GeneOntologyBiologicalProcessregulation of glucocorticoid secretion

CRY2 CRY1

4.35e-0414462GO:2000849
GeneOntologyBiologicalProcessresponse to morphine

DRD2 ADCY8

5.02e-0415462GO:0043278
GeneOntologyBiologicalProcessglucocorticoid secretion

CRY2 CRY1

5.72e-0416462GO:0035933
GeneOntologyBiologicalProcessresponse to isoquinoline alkaloid

DRD2 ADCY8

5.72e-0416462GO:0014072
GeneOntologyBiologicalProcesscircadian regulation of gene expression

CRY2 DRD2 CRY1

6.26e-0475463GO:0032922
GeneOntologyBiologicalProcessnuclear receptor-mediated glucocorticoid signaling pathway

CRY2 CRY1

6.48e-0417462GO:0042921
GeneOntologyBiologicalProcesslocomotion involved in locomotory behavior

DRD2 MYO5A

6.48e-0417462GO:0031987
GeneOntologyBiologicalProcessregulation of lipid transport

CRY2 IRAK1 SEC24A CRY1

6.73e-04179464GO:0032368
GeneOntologyBiologicalProcessnegative regulation of lipid localization

CRY2 IRAK1 CRY1

7.02e-0478463GO:1905953
GeneOntologyBiologicalProcessnuclear receptor-mediated corticosteroid signaling pathway

CRY2 CRY1

7.28e-0418462GO:0031958
GeneOntologyBiologicalProcessnegative regulation of synaptic transmission

DRD2 MYO5A ADCY8

7.56e-0480463GO:0050805
GeneOntologyBiologicalProcessregulation of growth hormone secretion

CHD7 DRD2

8.12e-0419462GO:0060123
GeneOntologyBiologicalProcesslipid transport

CRY2 IRAK1 DRD2 XKR6 SEC24A CRY1

8.62e-04506466GO:0006869
GeneOntologyBiologicalProcessprepulse inhibition

CHD8 DRD2

9.01e-0420462GO:0060134
GeneOntologyBiologicalProcessregulation of corticosteroid hormone secretion

CRY2 CRY1

9.95e-0421462GO:2000846
GeneOntologyBiologicalProcessgrowth hormone secretion

CHD7 DRD2

1.09e-0322462GO:0030252
GeneOntologyBiologicalProcessresponse to peptide hormone

CRY2 MYO5A PIK3C2A UMODL1 ADCY8 CRY1

1.10e-03530466GO:0043434
GeneOntologyBiologicalProcessregulation of hormone secretion

CRY2 CHD7 DRD2 ADCY8 CRY1

1.13e-03355465GO:0046883
GeneOntologyBiologicalProcessorganic hydroxy compound transport

IRAK1 DRD2 ACACB MYO5A SEC24A

1.17e-03358465GO:0015850
GeneOntologyBiologicalProcessnegative regulation of catecholamine secretion

DRD2 MYO5A

1.19e-0323462GO:0033604
GeneOntologyBiologicalProcessphosphatidylinositol-mediated signaling

PIK3C2A PI4KA

1.30e-0324462GO:0048015
GeneOntologyBiologicalProcesscorticosteroid hormone secretion

CRY2 CRY1

1.30e-0324462GO:0035930
GeneOntologyBiologicalProcessresponse to glucagon

ADCY8 CRY1

1.41e-0325462GO:0033762
GeneOntologyBiologicalProcessentrainment of circadian clock by photoperiod

CRY2 CRY1

1.41e-0325462GO:0043153
GeneOntologyBiologicalProcessadenylate cyclase-activating adrenergic receptor signaling pathway

DRD2 GPR101

1.41e-0325462GO:0071880
GeneOntologyBiologicalProcessregulation of monoatomic cation transmembrane transport

CHD7 DRD2 MYO5A PIK3C2A SCN5A

1.52e-03380465GO:1904062
GeneOntologyBiologicalProcesschemical homeostasis

CRY2 CHD7 DRD2 ACACB MYO5A ADCY8 SEC24A CYB561D2 CRY1

1.53e-031249469GO:0048878
GeneOntologyBiologicalProcessnegative regulation of hormone secretion

CRY2 DRD2 CRY1

1.57e-03103463GO:0046888
GeneOntologyBiologicalProcesspositive regulation of MAPK cascade

IRAK1 ZNF622 DRD2 GPR101 MAP3K3 IL26

1.60e-03571466GO:0043410
GeneOntologyBiologicalProcesslipid storage

CRY2 ACACB CRY1

1.66e-03105463GO:0019915
GeneOntologyBiologicalProcessresponse to nitrogen compound

CRY2 IRAK1 DRD2 EDEM1 MYO5A PIK3C2A UMODL1 ADCY8 CRY1

1.74e-031272469GO:1901698
MousePhenoabnormal periosteum morphology

XYLT1 CHD7

1.93e-053362MP:0010971
DomainDNA_photolyase

CRY2 CRY1

5.68e-062452PF00875
DomainDNA_photolyase_N

CRY2 CRY1

5.68e-062452IPR006050
DomainFAD_binding_7

CRY2 CRY1

5.68e-062452PF03441
DomainCryptochr/Photolyase_FAD-bd

CRY2 CRY1

5.68e-062452IPR005101
DomainPHR_CRY_ALPHA_BETA

CRY2 CRY1

5.68e-062452PS51645
DomainSNF2_N

CHD8 CHD7 RAD54L

6.17e-0532453IPR000330
DomainSNF2_N

CHD8 CHD7 RAD54L

6.17e-0532453PF00176
DomainBRK

CHD8 CHD7

8.46e-056452SM00592
DomainBRK_domain

CHD8 CHD7

8.46e-056452IPR006576
DomainBRK

CHD8 CHD7

8.46e-056452PF07533
DomainPI3Ka

PIK3C2A PI4KA

2.02e-049452PF00613
Domain-

PIK3C2A PI4KA

2.02e-0494521.25.40.70
DomainPI3Ka

PIK3C2A PI4KA

2.02e-049452SM00145
DomainPIK_HELICAL

PIK3C2A PI4KA

2.52e-0410452PS51545
DomainPI_Kinase

PIK3C2A PI4KA

2.52e-0410452IPR015433
DomainPInositide-3_kin_accessory_dom

PIK3C2A PI4KA

2.52e-0410452IPR001263
DomainTIL

VWF ZAN

3.69e-0412452PF01826
DomainC8

VWF ZAN

3.69e-0412452PF08742
DomainUnchr_dom_Cys-rich

VWF ZAN

4.35e-0413452IPR014853
DomainC8

VWF ZAN

4.35e-0413452SM00832
DomainTIL_dom

VWF ZAN

5.07e-0414452IPR002919
DomainPI3/4_kinase_CS

PIK3C2A PI4KA

5.84e-0415452IPR018936
DomainVWD

VWF ZAN

6.67e-0416452SM00216
DomainVWF_type-D

VWF ZAN

6.67e-0416452IPR001846
Domain-

PIK3C2A PI4KA

6.67e-04164521.10.1070.11
DomainVWFD

VWF ZAN

6.67e-0416452PS51233
DomainPI3Kc

PIK3C2A PI4KA

6.67e-0416452SM00146
DomainVWD

VWF ZAN

6.67e-0416452PF00094
DomainP-loop_NTPase

ASPM MYO1G CHD8 CHD7 MYO5A SMC3 ATAD3A RAD54L

8.45e-04848458IPR027417
DomainPI3/4_kinase_cat_dom

PIK3C2A PI4KA

8.47e-0418452IPR000403
DomainPI3_PI4_kinase

PIK3C2A PI4KA

8.47e-0418452PF00454
DomainPI3_4_KINASE_3

PIK3C2A PI4KA

8.47e-0418452PS50290
DomainPI3_4_KINASE_1

PIK3C2A PI4KA

8.47e-0418452PS00915
DomainPI3_4_KINASE_2

PIK3C2A PI4KA

8.47e-0418452PS00916
DomainVWC_out

VWF ZAN

9.46e-0419452SM00215
DomainIQ

ASPM MYO5A SCN5A

9.78e-0481453SM00015
DomainIQ_motif_EF-hand-BS

ASPM MYO5A SCN5A

1.33e-0390453IPR000048
DomainIQ

ASPM MYO5A SCN5A

1.46e-0393453PS50096
DomainChromo_domain

CHD8 CHD7

1.51e-0324452IPR023780
DomainChromo

CHD8 CHD7

1.78e-0326452PF00385
DomainCHROMO_1

CHD8 CHD7

2.06e-0328452PS00598
DomainCHROMO_2

CHD8 CHD7

2.06e-0328452PS50013
DomainHelicase_C

CHD8 CHD7 RAD54L

2.18e-03107453PF00271
DomainHELICc

CHD8 CHD7 RAD54L

2.18e-03107453SM00490
DomainHelicase_C

CHD8 CHD7 RAD54L

2.24e-03108453IPR001650
DomainHELICASE_CTER

CHD8 CHD7 RAD54L

2.30e-03109453PS51194
DomainHELICASE_ATP_BIND_1

CHD8 CHD7 RAD54L

2.30e-03109453PS51192
DomainDEXDc

CHD8 CHD7 RAD54L

2.30e-03109453SM00487
DomainHelicase_ATP-bd

CHD8 CHD7 RAD54L

2.36e-03110453IPR014001
DomainChromodomain-like

CHD8 CHD7

2.69e-0332452IPR016197
DomainChromo/shadow_dom

CHD8 CHD7

2.86e-0333452IPR000953
DomainCHROMO

CHD8 CHD7

2.86e-0333452SM00298
DomainDNA/RNA_helicase_DEAH_CS

CHD8 CHD7

3.21e-0335452IPR002464
DomainVWFC_1

VWF ZAN

3.39e-0336452PS01208
DomainVWC

VWF ZAN

3.78e-0338452SM00214
DomainDEAH_ATP_HELICASE

CHD8 CHD7

3.78e-0338452PS00690
DomainMyosin_head_motor_dom

MYO1G MYO5A

3.78e-0338452IPR001609
DomainVWFC_2

VWF ZAN

3.78e-0338452PS50184
DomainMYOSIN_MOTOR

MYO1G MYO5A

3.78e-0338452PS51456
DomainMyosin_head

MYO1G MYO5A

3.78e-0338452PF00063
DomainMYSc

MYO1G MYO5A

3.78e-0338452SM00242
DomainVWF_dom

VWF ZAN

4.60e-0342452IPR001007
PathwayBIOCARTA_CIRCADIAN_PATHWAY

CRY2 CRY1

9.99e-056372M22067
PathwayWP_MELATONIN_METABOLISM_AND_EFFECTS

CRY2 IRAK1 CRY1

1.22e-0437373M39418
PathwayBIOCARTA_CIRCADIAN_PATHWAY

CRY2 CRY1

1.40e-047372MM1578
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

MRPL17 IRAK1 CHD8 CHD7 TTF1 ATAD3A PI4KA

1.26e-0641047726949251
Pubmed

Delay in feedback repression by cryptochrome 1 is required for circadian clock function.

CRY2 CRY1

1.79e-06247221236481
Pubmed

CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.

CRY2 CRY1

1.79e-06247225391456
Pubmed

Loss of circadian rhythm and light-induced suppression of pineal melatonin levels in Cry1 and Cry2 double-deficient mice.

CRY2 CRY1

1.79e-06247220825493
Pubmed

The ratio of intracellular CRY proteins determines the clock period length.

CRY2 CRY1

1.79e-06247226966073
Pubmed

Cognitive dysfunction, elevated anxiety, and reduced cocaine response in circadian clock-deficient cryptochrome knockout mice.

CRY2 CRY1

1.79e-06247224187535
Pubmed

The circadian clock components CRY1 and CRY2 are necessary to sustain sex dimorphism in mouse liver metabolism.

CRY2 CRY1

1.79e-06247219211562
Pubmed

Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism.

CRY2 CRY1

1.79e-06247228380384
Pubmed

The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location.

CRY2 CRY1

1.79e-06247229940771
Pubmed

Mice deficient in cryptochrome 1 (cry1 (-/-)) exhibit resistance to obesity induced by a high-fat diet.

CRY2 CRY1

1.79e-06247224782829
Pubmed

Redox potential: differential roles in dCRY and mCRY1 functions.

CRY2 CRY1

1.79e-06247211818067
Pubmed

Circadian oscillation of nucleotide excision repair in mammalian brain.

CRY2 CRY1

1.79e-06247219164551
Pubmed

Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2.

CRY2 CRY1

1.79e-06247210518585
Pubmed

Circadian intraocular pressure rhythm is generated by clock genes.

CRY2 CRY1

1.79e-06247216936122
Pubmed

Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms.

CRY2 CRY1

1.79e-06247210217146
Pubmed

Pleiotropic effects of cryptochromes 1 and 2 on free-running and light-entrained murine circadian rhythms.

CRY2 CRY1

1.79e-06247212696673
Pubmed

Analysis of autophosphorylating kinase activities of Arabidopsis and human cryptochromes.

CRY2 CRY1

1.79e-06247217073458
Pubmed

Mammalian cryptochromes impinge on cell cycle progression in a circadian clock-independent manner.

CRY2 CRY1

1.79e-06247222033214
Pubmed

Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains.

CRY2 CRY1

1.79e-06247218614689
Pubmed

Characterization of photolyase/blue-light receptor homologs in mouse and human cells.

CRY2 CRY1

1.79e-0624729801304
Pubmed

Synchronization of cellular clocks in the suprachiasmatic nucleus.

CRY2 CRY1

1.79e-06247214631044
Pubmed

Autonomic and cardiovascular responses to scent stimulation are altered in cry KO mice.

CRY2 CRY1

1.79e-06247217175102
Pubmed

Measurement of internal body time by blood metabolomics.

CRY2 CRY1

1.79e-06247219487679
Pubmed

Further characterization of the phenotype of mCry1/mCry2-deficient mice.

CRY2 CRY1

1.79e-06247211587085
Pubmed

Cancer, hear my battle CRY.

CRY2 CRY1

1.79e-06247232291799
Pubmed

CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.

CHD8 CHD7

1.79e-06247220453063
Pubmed

Suppression of circadian clock protein cryptochrome 2 promotes osteoarthritis.

CRY2 CRY1

1.79e-06247232339698
Pubmed

Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins.

CRY2 CRY1

1.79e-0624728909283
Pubmed

CRY1 and CRY2 genetic variants in seasonality: A longitudinal and cross-sectional study.

CRY2 CRY1

1.79e-06247227267441
Pubmed

Vagal regulation of respiratory clocks in mice.

CRY2 CRY1

1.79e-06247217442820
Pubmed

Circadian rhythm of RNA N6-methyladenosine and the role of cryptochrome.

CRY2 CRY1

1.79e-06247226239657
Pubmed

Altered food-anticipatory activity rhythm in Cryptochrome-deficient mice.

CRY2 CRY1

1.79e-06247215893577
Pubmed

Circadian behavioral rhythms in Cry1/Cry2 double-deficient mice induced by methamphetamine.

CRY2 CRY1

1.79e-06247218258761
Pubmed

Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.

CHD8 CHD7

1.79e-06247224211491
Pubmed

Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha.

CRY2 CRY1

1.79e-06247220042581
Pubmed

Interval timing is intact in arrhythmic Cry1/Cry2-deficient mice.

CRY2 CRY1

1.79e-06247221775289
Pubmed

Control of skin cancer by the circadian rhythm.

CRY2 CRY1

1.79e-06247222025708
Pubmed

Circadian time-place learning in mice depends on Cry genes.

CRY2 CRY1

1.79e-06247218514517
Pubmed

Altered phase-relationship between peripheral oscillators and environmental time in Cry1 or Cry2 deficient mouse models for early and late chronotypes.

CRY2 CRY1

1.79e-06247224386234
Pubmed

Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses.

CRY2 CRY1

1.79e-0624729822380
Pubmed

The Potorous CPD photolyase rescues a cryptochrome-deficient mammalian circadian clock.

CRY2 CRY1

1.79e-06247221858120
Pubmed

Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein kinase.

CRY2 CRY1

1.79e-06247215298678
Pubmed

Structural differences in the FAD-binding pockets and lid loops of mammalian CRY1 and CRY2 for isoform-selective regulation.

CRY2 CRY1

1.79e-06247234172584
Pubmed

Cryptochrome-deficient mice lack circadian electrical activity in the suprachiasmatic nuclei.

CRY2 CRY1

1.79e-06247212121621
Pubmed

Expression of the blue-light receptor cryptochrome in the human retina.

CRY2 CRY1

1.79e-06247214507900
Pubmed

Light signalling in cryptochrome-deficient mice.

CRY2 CRY1

1.79e-06247214712914
Pubmed

Circadian clock-dependent and -independent rhythmic proteomes implement distinct diurnal functions in mouse liver.

CRY2 CRY1

1.79e-06247224344304
Pubmed

Postnatal constant light compensates Cryptochrome1 and 2 double deficiency for disruption of circadian behavioral rhythms in mice under constant dark.

CRY2 CRY1

1.79e-06247224278295
Pubmed

High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice.

CRY2 CRY1

1.79e-06247223531614
Pubmed

Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer.

CRY2 CRY1

1.79e-06247216061665
Pubmed

Daily variation in the electrophysiological activity of mouse medial habenula neurones.

CRY2 CRY1

1.79e-06247224247982
Pubmed

Deregulated expression of cryptochrome genes in human colorectal cancer.

CRY2 CRY1

1.79e-06247226768731
Pubmed

Network features of the mammalian circadian clock.

CRY2 CRY1

1.79e-06247219278294
Pubmed

Perspectives: neurobiology. The CRYs fo flies and mice.

CRY2 CRY1

1.79e-06247210636810
Pubmed

Photolyase/cryptochrome blue-light photoreceptors use photon energy to repair DNA and reset the circadian clock.

CRY2 CRY1

1.79e-06247212483519
Pubmed

Circadian clock cryptochrome proteins regulate autoimmunity.

CRY2 CRY1

1.79e-06247229109286
Pubmed

Reduced light response of neuronal firing activity in the suprachiasmatic nucleus and optic nerve of cryptochrome-deficient mice.

CRY2 CRY1

1.79e-06247222216107
Pubmed

Deregulated expression of cry1 and cry2 in human gliomas.

CRY2 CRY1

1.79e-06247223317246
Pubmed

Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines.

CRY2 CRY1

1.79e-06247222778400
Pubmed

Knockout-Rescue Embryonic Stem Cell-Derived Mouse Reveals Circadian-Period Control by Quality and Quantity of CRY1.

CRY2 CRY1

1.79e-06247228017587
Pubmed

A role for cryptochromes in sleep regulation.

CRY2 CRY1

1.79e-06247212495442
Pubmed

Restoring the Molecular Clockwork within the Suprachiasmatic Hypothalamus of an Otherwise Clockless Mouse Enables Circadian Phasing and Stabilization of Sleep-Wake Cycles and Reverses Memory Deficits.

CRY2 CRY1

1.79e-06247234446572
Pubmed

Clock gene defect disrupts light-dependency of autonomic nerve activity.

CRY2 CRY1

1.79e-06247217964540
Pubmed

Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression.

CRY2 CRY1

1.79e-06247219940241
Pubmed

Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver.

CRY2 CRY1

1.79e-06247227818260
Pubmed

The involvement of Cry1 and Cry2 genes in the regulation of the circadian body temperature rhythm in mice.

CRY2 CRY1

1.79e-06247215331384
Pubmed

Cryptochromes are critical for the development of coherent circadian rhythms in the mouse suprachiasmatic nucleus.

CRY2 CRY1

1.79e-06247223575670
Pubmed

MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.

IRAK1 WDR41 EDEM1 SMC3 POLE

1.85e-0615047522678362
Pubmed

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.

FLNB SMC3 ATAD3A PI4KA

2.81e-067247436376293
Pubmed

Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis.

CRY2 CRY1

5.36e-06347221628572
Pubmed

Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8.

CHD8 CHD7

5.36e-06347230108144
Pubmed

Regulation of apoptosis by the circadian clock through NF-kappaB signaling.

CRY2 CRY1

5.36e-06347221690409
Pubmed

Reduced alpha-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock.

CRY2 CRY1

5.36e-06347215860530
Pubmed

Molecular clocks in mouse skin.

CRY2 CRY1

5.36e-06347219037239
Pubmed

Further evidence for the role of cryptochromes in retinohypothalamic photoreception/phototransduction.

CRY2 CRY1

5.36e-06347215010208
Pubmed

Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression.

CRY2 CRY1

5.36e-06347216970803
Pubmed

Cell-autonomous clock of astrocytes drives circadian behavior in mammals.

CRY2 CRY1

5.36e-06347230630934
Pubmed

Quantitative analyses of cryptochrome-mBMAL1 interactions: mechanistic insights into the transcriptional regulation of the mammalian circadian clock.

CRY2 CRY1

5.36e-06347221521686
Pubmed

Loss of cryptochrome reduces cancer risk in p53 mutant mice.

CRY2 CRY1

5.36e-06347219188586
Pubmed

CRY1-CBS binding regulates circadian clock function and metabolism.

CRY2 CRY1

5.36e-06347232383312
Pubmed

Circadian and Feeding Rhythms Orchestrate the Diurnal Liver Acetylome.

CRY2 CRY1

5.36e-06347228813682
Pubmed

A circadian clock regulates efflux by the blood-brain barrier in mice and human cells.

CRY2 CRY1

5.36e-06347233504784
Pubmed

Circadian clock genes directly regulate expression of the Na(+)/H(+) exchanger NHE3 in the kidney.

CRY2 CRY1

5.36e-06347215780093
Pubmed

Cryptochrome-dependent circadian periods in the arcuate nucleus.

CRY2 CRY1

5.36e-06347226542738
Pubmed

Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein.

CRY2 CRY1

5.36e-06347211889036
Pubmed

Loss of circadian rhythmicity in aging mPer1-/-mCry2-/- mutant mice.

CRY2 CRY1

5.36e-06347212782655
Pubmed

Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes.

CRY2 CRY1

5.36e-06347212865428
Pubmed

DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells.

CRY2 CRY1

5.36e-06347223149912
Pubmed

Differential roles for cryptochromes in the mammalian retinal clock.

CRY2 CRY1

5.36e-06347229561690
Pubmed

Timed exercise stabilizes behavioral rhythms but not molecular programs in the brain's suprachiasmatic clock.

CRY2 CRY1

5.36e-06347236866044
Pubmed

Intrinsic and extrinsic cues regulate the daily profile of mouse lateral habenula neuronal activity.

CRY2 CRY1

5.36e-06347225194046
Pubmed

Circadian regulation of food-anticipatory activity in molecular clock-deficient mice.

CRY2 CRY1

5.36e-06347223145013
Pubmed

Translational switching of Cry1 protein expression confers reversible control of circadian behavior in arrhythmic Cry-deficient mice.

CRY2 CRY1

5.36e-06347230487216
Pubmed

Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm.

CRY2 CRY1

5.36e-06347222549838
Pubmed

Effect of vitamin A depletion on nonvisual phototransduction pathways in cryptochromeless mice.

CRY2 CRY1

5.36e-06347215523112
Pubmed

Season-dependent associations of circadian rhythm-regulating loci (CRY1, CRY2 and MTNR1B) and glucose homeostasis: the GLACIER Study.

CRY2 CRY1

5.36e-06347225707907
Pubmed

Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein.

CRY2 CRY1

5.36e-06347221193487
Pubmed

Suprachiasmatic nucleus grafts restore circadian behavioral rhythms of genetically arrhythmic mice.

CRY2 CRY1

5.36e-06347212699623
Pubmed

Lithium effects on circadian rhythms in fibroblasts and suprachiasmatic nucleus slices from Cry knockout mice.

CRY2 CRY1

5.36e-06347226930624
Pubmed

Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders.

ASPM DRD2

5.36e-06347224849541
InteractionMKI67 interactions

ASPM MRPL17 IRAK1 CHD8 CHD7 SMC3 TTF1 ATAD3A PI4KA

1.09e-05648459int:MKI67
InteractionDNAJC7 interactions

CRY2 IRAK1 GREB1 WDR41 PIK3C2A PI4KA POLE

4.01e-05425457int:DNAJC7
InteractionPTGES3 interactions

IRAK1 CHD7 GREB1 PIK3C2A PI4KA POLE RAD54L

4.78e-05437457int:PTGES3
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

CHD7 TTF1

3.71e-0353312532
CoexpressionGSE17721_CTRL_VS_POLYIC_24H_BMDC_UP

MYO5A CTSA PIK3C2A SMC3 ADCY8

2.55e-05199465M3723
CoexpressionGSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP

TIGD2 PI4KA MAP3K3 POLR2F CYB561D2

2.55e-05199465M9220
ToppCellCOVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations)

ASPM XKR6 EDEM1 SEC24A IL26

1.41e-06183475130c109f63a5e3c8f83cb96e32f4addf513b6415
ToppCellCOVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations)

ASPM XKR6 EDEM1 SEC24A IL26

1.41e-061834752c016bb59f131a0e821853b085289a3583f0a729
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM VWF ACACB TTF1

7.60e-06119474c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCellGlobus_pallidus|World / BrainAtlas - Mouse McCarroll V32

IRAK1 GPR101 ZAN SCN5A

9.53e-0612647444b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCellTracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

XYLT1 SLC5A10 SPIB ZNF331

2.95e-05168474c34dd4a9c54d8e9c8f118e6a3816548890cb0746
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

TRGV4 MYO1G IRAK1 CYB561D2

3.31e-051734747714d27e53b02af4e071154cf2ea001fab347235
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ASPM CCR3 POLE BICC1

3.62e-051774743e149bff1f1b393a7abe98984e37981c8296f95d
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GREB1 SLC5A10 ADCY8 BICC1

3.78e-0517947458ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SLC5A10 GPR101 FAM187A

3.87e-0562473a20620a8869721ea62984c2022ee1b484b455824
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SLC5A10 GPR101 FAM187A

3.87e-0562473ee694c06bcd924b4ddf744178ba3a99e04eed51b
ToppCellwk_08-11-Hematologic-Myeloid-pre-pDC/DC5|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

TRGV4 ZAN SPIB UMODL1

4.03e-05182474fec8a2d6d4099722b8e1bb41222108ed74268fcf
ToppCellURO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type

ASPM RAD54L IL26 SCN5A

4.30e-051854740ae9c646679c69a553eda670aef0e0495feb0286
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM MYO1G CCR3 RAD54L

4.77e-05190474b69940d16685249167d4c2cf6ad8237ccf6f7590
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ASPM POLE RAD54L ZNF331

4.77e-05190474d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellControl-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class

CHD7 PIK3C2A CYB561D2 CRY1

5.27e-051954748679a122fe796b1eddef82460e985b3fd3b3a2a5
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPM VWF ZAN RAD54L

5.49e-0519747476b61e60a757e58b465569538e632d6d9953e89a
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FLNB CHD7 VWF PIK3C2A

5.82e-05200474dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellCOVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

ASPM SMC3 POLE RAD54L

5.82e-0520047404bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCellCOVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

ASPM SMC3 POLE RAD54L

5.82e-05200474f6b5320cdfe640a71e6e2df26f30d42e64b1c921
DiseaseMental Depression

CRY2 DRD2 ADCY8 BICC1 CRY1

4.19e-05254455C0011570
DiseaseCOVID-19, obesity

CCR3 ADCY8

4.75e-057452EFO_0001073, MONDO_0100096
DiseaseCHARGE syndrome (implicated_via_orthology)

CHD8 CHD7

4.75e-057452DOID:0050834 (implicated_via_orthology)
DiseaseDepressive disorder

CRY2 DRD2 ADCY8 BICC1 CRY1

7.72e-05289455C0011581
Diseaseaggressive behaviour measurement, ADHD symptom measurement

XYLT1 DRD2 XKR6

1.55e-0468453EFO_0007826, EFO_0007860
DiseaseSeasonal Affective Disorder

CRY2 CRY1

2.69e-0416452C0085159
Diseasecoagulation factor measurement

ASPM VWF

4.25e-0420452EFO_0004634
Diseasebrain ischemia (biomarker_via_orthology)

IRAK1 DRD2 SCN5A

5.12e-04102453DOID:2316 (biomarker_via_orthology)
DiseaseMyeloid Leukemia, Chronic

CRY2 CRY1

8.99e-0429452C0023473
DiseaseAstigmatism

XYLT1 MYO1G BICC1

1.01e-03129453HP_0000483
DiseaseHyperkinesia, Generalized

DRD2 ADCY8

1.10e-0332452C0751217
DiseaseHyperkinesia

DRD2 ADCY8

1.10e-0332452C3887506
Diseaseinternet addiction disorder

IRAK1 FLNB

1.17e-0333452EFO_0803368

Protein segments in the cluster

PeptideGeneStartEntry
LIVRYQRMNGRYNFK

UMODL1

1291

Q5DID0
NGRRIYYGMNALRAK

TTF1

751

Q15361
QRYFLGQRRKSEVVM

ADCY8

171

P40145
RLVTAYQRSYKREQM

CHD8

1751

Q9HCK8
RYRTMGNVARRKYAA

ARSI

251

Q5FYB1
TKKNRSLYRNILMYG

ATAD3A

386

Q9NVI7
HLYRTQYLKGVNRSM

FAM187A

306

A6NFU0
FKQRSRMYGATVIVR

BICC1

241

Q9H694
LITAYQRSYKRQQMR

CHD7

1916

Q9P2D1
QAFVRGYLVRKQMRL

ASPM

1736

Q8IZT6
IQVRCRAYYQGKMQR

ASPM

2146

Q8IZT6
RRYLYVRLDGTMSIK

RAD54L

536

Q92698
QRYRSGIRGYMKTVV

ACACB

1116

O00763
YIQRSRRLYGNTPMR

KIAA0100

946

Q14667
LYVRRQTARMRLSKY

GREB1

1446

Q4ZG55
VLSQKRMYRKYHQRP

FLNB

56

O75369
MLVYSGYSKETLRQR

PIK3C2A

1626

O00443
QIVQALRYDKMGYVR

PI4KA

1656

P42356
YRKVNRVLPRSNMVY

POLE

1381

Q07864
SKMTQRRGYLLLYGT

GPR101

141

Q96P66
VYRAVMRNTVYAVKR

IRAK1

226

P51617
RRLYRSMNSQYLKLL

CTSA

371

P10619
KYRRLRIMTNIYLLN

CCR3

61

P51677
ERMKQIYQQLSRYRG

CRY2

501

Q49AN0
IERMKQIYQQLSRYR

CRY1

481

Q16526
RMKRIFYRIGNKGIY

IL26

136

Q9NPH9
RRYSLPLKSIYMRQI

EDEM1

636

Q92611
LYNTRYSSKRRVTVM

DRD2

141

P14416
IMNQVSNAYLYRKRI

CYB561D2

206

O14569
TRKYTRQILEGMSYL

MAP3K3

466

Q99759
MYIKQVIIQGFRSYR

SMC3

1

Q9UQE7
QRYLTRKIGFEAVMR

SEC24A

736

O95486
RLYQQTLRSAGKIYM

SCN5A

376

Q14524
YMTKYERARVLGTRA

POLR2F

56

P61218
RMTYQKLARALRNYA

SPIB

221

Q01892
MSQGVLATVKRYYRA

TIGD2

326

Q4W5G0
YIRTMYLGIQSQRRK

XKR6

256

Q5GH73
GRASRQLQRMFKAIY

XYLT1

336

Q86Y38
QRMSRNFVRYVQGLK

VWF

1391

P04275
KRYGGQRIRMYLSVL

SLC5A10

126

A0PJK1
RLRQQLEMYSISRKY

SMIM19

76

Q96E16
RGRYVNQMIINYVKR

ZNF331

96

Q9NQX6
YDTYGSTRKNLRMIL

TRGV4

86

A0A0C4DH28
LMRYYKQRFGLSRAV

ZNF622

396

Q969S3
GRGLYVYSLQMKRVI

WDR41

301

Q9HAD4
RYKDQTGGYTRMLQI

MRPL17

96

Q9NRX2
SYRLQGRMTYVLIKT

ZAN

2346

Q9Y493
MRNLQLRFEKGRIYT

MYO1G

26

B0I1T2
KAAITMQRYVRGYQA

MYO5A

791

Q9Y4I1